Insider Trading History of Barrows Craig

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Barrows Craig since 2007. The trader's CIK number is 1177813. At the time of the last reporting, Barrows Craig was the VP, General Counsel of Immunogen, Inc.. (stock ticker symbol IMGN). Also see all insider trading activities at Immunogen, Inc..

Note that in the past BARROWS CRAIG also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Mercury Systems Inc (MRCY) by Barrows Craig

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 MRCY 0 $0 1,241 $15,518 0 $0

Yearly summary of insider trading at Immunogen, Inc. (IMGN) by Barrows Craig

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2020 IMGN 0 $0 16,492 $82,295 0 $0
2018 IMGN 0 $0 14,870 $83,272 0 $0
2018 IMGN 0 $0 15,498 $168,618 0 $0
2017 IMGN 0 $0 37,050 $252,454 50,000 $225,000
2016 IMGN 10,000 $17,080 0 $0 0 $0
2014 IMGN 0 $0 0 $0 15,000 $49,500


Insider trading activities at 2 companies by Barrows Craig:

1. Mercury Systems Inc (MRCY)

2. Immunogen, Inc. (IMGN)

Table 1. Insider trading of Mercury Systems Inc (MRCY) by Barrows Craig

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-03-12 MRCY Sale 1,241 12.51 15,518

Table 2. Insider trading of Immunogen, Inc. (IMGN) by Barrows Craig

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2020-02-24 IMGN Sale 16,492 4.99 82,295
2018-02-22 IMGN Sale 14,870 5.60 83,272
2018-02-21 IMGN Sale 15,498 10.88 168,618
2017-09-13 IMGN Option Ex 20,000 4.50 90,000
2017-09-13 IMGN Sale 14,600 6.95 101,411
2017-09-15 IMGN Option Ex 30,000 4.50 135,000
2017-09-15 IMGN Sale 22,450 6.73 151,043
2016-11-02 IMGN Buy 10,000 1.71 17,080
2014-05-05 IMGN Option Ex 15,000 3.30 49,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Barrows Craig (VP, General Counsel of Immunogen, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.